| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lyell Immunopharma, Inc. | Chief Financial Officer | Common Stock | 48.7K | $111K | $2.28 | Feb 9, 2024 | Direct |
| 2seventy bio, Inc. | Director | Common Stock | 22.6K | $94.6K | $4.18 | Jun 10, 2024 | Direct |
| 2seventy bio, Inc. | Director | Stock Options (Right to buy) | 12.1K | $47.4K | $3.93 | Jun 10, 2024 | Direct |
| Lyell Immunopharma, Inc. | Chief Financial Officer | Stock Option (right to buy) | 400K | Feb 9, 2024 | Direct | ||
| Coherus BioSciences, Inc. | Director | Stock Option (Right to Buy) | 112K | Jun 3, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TSVT | 2seventy bio, Inc. | Jun 10, 2024 | 2 | $0 | 4 | Jun 12, 2024 | Director |
| CHRS | Coherus BioSciences, Inc. | Jun 3, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Director |
| TSVT | 2seventy bio, Inc. | Mar 20, 2024 | 2 | $0 | 4 | Mar 25, 2024 | Director |
| TSVT | 2seventy bio, Inc. | Mar 20, 2024 | 0 | $0 | 3 | Mar 25, 2024 | Director |
| LYEL | Lyell Immunopharma, Inc. | Feb 9, 2024 | 2 | $0 | 4 | Feb 13, 2024 | Chief Financial Officer |
| LYEL | Lyell Immunopharma, Inc. | Nov 16, 2023 | 8 | $0 | 4 | Nov 20, 2023 | Chief Financial Officer |
| CHRS | Coherus BioSciences, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
| LYEL | Lyell Immunopharma, Inc. | Feb 24, 2023 | 1 | $0 | 4 | Feb 28, 2023 | Chief Financial Officer |
| CHRS | Coherus BioSciences, Inc. | May 4, 2022 | 1 | $0 | 4 | May 6, 2022 | Director |
| CHRS | Coherus BioSciences, Inc. | May 4, 2022 | 0 | $0 | 3 | May 6, 2022 | Director |
| CHRS | Coherus BioSciences, Inc. | May 4, 2022 | 0 | $0 | 3 | May 6, 2022 | Director |
| LYEL | Lyell Immunopharma, Inc. | Mar 16, 2022 | 1 | $0 | 4 | Mar 18, 2022 | Chief Financial Officer |
| LYEL | Lyell Immunopharma, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 16, 2021 | Chief Financial Officer |